LIU Lina, LIU Xiaodong, ZHAO Limei. Pharmaceutical care on a diabetic patient with invasive pulmonary aspergillosis[J]. Journal of Pharmaceutical Practice and Service, 2014, 32(5): 389-392. doi: 10.3969/j.issn.1006-0111.2014.05.022
Citation:
|
LIU Lina, LIU Xiaodong, ZHAO Limei. Pharmaceutical care on a diabetic patient with invasive pulmonary aspergillosis[J]. Journal of Pharmaceutical Practice and Service, 2014, 32(5): 389-392. doi: 10.3969/j.issn.1006-0111.2014.05.022
|
Pharmaceutical care on a diabetic patient with invasive pulmonary aspergillosis
- 1.
Department of Pharmacy, Shengjing Hospital of China Medical University, Shenyang 110004, China;Department of Pharmacy, Second Affiliated Hospital (Binjiang Branch) of Zhejiang University School of Medicine, Hangzhou 310009, China
- 2.
Department of Pharmacy, Shengjing Hospital of China Medical University, Shenyang 110004, China
- Received Date: 2013-07-31
- Rev Recd Date:
2013-11-21
-
Abstract
Objective To investigate better patient care via the improved use of medicines and pharmaceutical services for hospital inpatients. Methods Through a case of invasive pulmonary aspergillosis in a diabetic patient, the efficacy of prescribed treatment was evaluated, and adverse drug reactions were prevented by clinical pharmacists. Results Pharmaceutical services were provided, adverse drug reactions were reduced and the use of medicines was improved by clinical pharmacists. Conclusion Clinical pharmacists could help provide tailored treatment to the needs of individuals, ensure patient safety and appropriate use of medicines.
-
References
[1]
|
中华内科杂志编辑委员会. 侵袭性肺部真菌感染的诊断标准与治疗原则[J]. 中华内科杂志, 2006, 45:697-700. |
[2]
|
何礼贤, 邵长周. 侵袭性肺曲霉病的分级诊断和治疗[J]. 中华结核和呼吸杂志, 2006, 29(5):297-298. |
[3]
|
Sanford JP//范洪伟, 吕 玮, 吴 东, 等译. 桑福德抗微生物治疗指南[M]. 41版,北京:中国协和医科大学出版社, 2011:102-103. |
[4]
|
Herbrecht R, Denning DW, Patterson TF, et al. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis[J]. New Engl J Med, 2002, 347:408-415. |
[5]
|
许改香, 童 茵, 毛莉萍. 两性霉素B治疗56例恶性血液病患者真菌感染的临床分析[J]. 中国实用医药, 2008, 3(26):117-119. |
[6]
|
Stefan W, David F, Roisin MF, et al. human tissue distribution of voriconazole[J]. Antimicrob Agents Chemother, 2011, 55(2):925-928. |
[7]
|
徐 翔. 注射药物相容性手册(1):抗菌药物分册[M]. 杭州:西泠印社出版社, 2005:34-42. |
[8]
|
中华医学会糖尿病学分会. 中国2型糖尿病防治指南(2010年版)[J]. 中国糖尿病杂志, 2012, 20(1):S1-S36. |
[9]
|
Kahn CR, Weir GC, King GL, et al//潘长玉主译. Joslin糖尿病学[M]. 14版.北京:人民卫生出版社, 2007:683-685, 771. |
[10]
|
蔡卫民. 我国医院药学面临的机遇与挑战[J]. 中国医院药学杂志, 2005, 25(5):471-472. |
-
-
Proportional views
-